Vitamin D supplementation and COVID‑19 risk: a population‑based, cohort study

Supplementation with cholecalciferol or calcifediol helped subject to achieve serum 25OHD levels ≥30 ng/ml which were associated with better COVID-19 outcomes. 

Vitamin D supplementation and COVID‑19 risk: a population‑based, cohort study2022-09-09T11:04:38-05:00

Changes in 25‐hydroxyvitamin D levels post‐vitamin D supplementation in people of Black and Asian ethnicities and its implications during COVID‐19 pandemic: A systematic review

This study recommends that people with darker skin supplement their diet with vitamin D3 through oral modes aiming to reduce the risk of adverse outcomes of...

Changes in 25‐hydroxyvitamin D levels post‐vitamin D supplementation in people of Black and Asian ethnicities and its implications during COVID‐19 pandemic: A systematic review2022-09-09T11:14:25-05:00

Impact of daily high dose oral vitamin D therapy on the inflammatory markers in patients with COVID 19 disease

Impact of daily high dose oral vitamin D therapy on the inflammatory markers

Impact of daily high dose oral vitamin D therapy on the inflammatory markers in patients with COVID 19 disease2022-05-10T12:32:45-05:00

Vitamin D supplementation and COVID-19 treatment: A systematic review and meta-analysis.

Vitamin D supplementation and COVID-19 treatment: A systematic review and meta-analysis. Take

Vitamin D supplementation and COVID-19 treatment: A systematic review and meta-analysis.2022-05-11T11:43:00-05:00

Effect of a Single High Dose of Vitamin D3 on Hospital Length

A high, single oral dose of 200,000 IU vitamin D3, compared to placebo, did not significantly reduce hospital length of stay in moderately to severely ill hospitalized patients diagnosed with COVID-19 in Brazil during the study period of June-August 2020.

Effect of a Single High Dose of Vitamin D3 on Hospital Length2022-05-10T12:29:26-05:00

Vitamin D supplementation and outcomes in coronavirus disease 2019 (COVID-19) patients from the outbreak area of Lombardy, Italy

This study did not find a benefit associated with vitamin D supplementation in COVID-19 patients but did identify that vitamin D deficiency may be a risk factor for higher in-patient mortality.

Vitamin D supplementation and outcomes in coronavirus disease 2019 (COVID-19) patients from the outbreak area of Lombardy, Italy2022-05-11T16:11:56-05:00

Habitual use of vitamin D supplements and risk of coronavirus disease 2019 (COVID-19) infection: a prospective study in UK Biobank

In this prospective study, the self-reported use of vitamin D supplements was associated with a lower risk of COVID-19 infection, independent of lifestyle, socio-economic status, prevalent chronic diseases and circulating...

Habitual use of vitamin D supplements and risk of coronavirus disease 2019 (COVID-19) infection: a prospective study in UK Biobank2022-05-11T16:13:24-05:00

Effectiveness of In-Hospital Cholecalciferol Use

Results from this retrospective analysis demonstrate that two consecutive doses of 200,000 IU cholecalciferol (total of 400,000 IU) can significantly improve the outcome in patients affected by COVID-19 that are also burdened with three or more...

Effectiveness of In-Hospital Cholecalciferol Use2022-05-11T16:14:26-05:00

High-Dose Cholecalciferol Booster Therapy

In this observational study, treatment with cholecalciferol booster therapy, regardless of baseline serum 25(OH)D levels, appears to be associated with a reduced risk of mortality in acute in-patients admitted with COVID-19.

High-Dose Cholecalciferol Booster Therapy2022-05-11T16:08:37-05:00